Gene ID Mutation allele                                        Cryptic (Alternative) Splice Site Phenotype
  #, Coordinate (Ri(n) /Ri(m)) Coordinate (Ri(m))  
CASQ2 1, IVS 4, D:G→A, 1 (8.4/-4.1) [14]   CPVT
CAV3 2, IVS 1, D: T→C, 2 (8.1/0.6) [25]   HCM
DES 3, IVS 3, D:A→G, 3 (9.5/7.0) [26]   DCM
DMD 4, IVS 1, D:G→A, 5 (9.5/5.9) [27]   DCM
  5, IVS 1, D:G→T, 1 (9.5/1.6) [28]   DCM
  6, IVS 1, D:T→C, 6 (9.5/8.0) [29]   DCM
  7, IVS 5, D:G→T, 1 (11.1/3.3) [30]   DCM
DSC2 8, IVS 15, D:G→A, 5  (7.6 /4.1) [31]   ARVD
DSG2 9, IVS 5, D:T→C, 2 (7.5/0.0) [31]   ARVD
  10, IVS 6, D:G→A, 1 (11.0/-1.8) [32]   ARVD
DSP 11, IVS 2, D:G→A, 5 (5.4/1.9) [33]   ARVD
  12, IVS 15, D:G→C, 1 (10.0/0.2) [34]   DCM
LMNA 13, IVS 5, D:G→T, 1 (6.0/-1.8) [35]   DCM
  14, IVS 6, D:G→A, 1 (10.6/-2.2) [36]   DCM
  15, IVS 7, D:G→A, 1 (7.1/-5.7) [37]   DCM
MYBPC3 16, IVS 4, D:G→C, 5 (8.8/4.9) [38]   HCM
  17, IVS 6, D:G→A, 5 (9.3/5.8) [39]   HCM
  18, IVS 7, D:G→A, 1 (8.7/-4.1) [40]   HCM
  19, IVS 7, D:G→A, 5 (8.7/5.2) [41]   HCM
  20, IVS 7, D:G→T, 1 (8.7/0.9) [42]   HCM
  21, IVS 12, D:G→A, -1 (6.6/-9.3) [43]   HCM
  22, IVS 12, D:G→A, 1 (6.6/-26.1) [44] IVS 12, D, 4 (3.5) HCM
  23, IVS 12, D:G→C, 1 (6.6/-23.1) [45] IVS 12, D, 2 (2.6) HCM
  24, IVS 13, D:G→C, 1 (4.3/-5.5) [45]   HCM
  25, IVS 13, D:G→T, 1 (4.3/-3.5) [46]   HCM
  26, IVS 15, D:G→A, 1 (8.0/-4.8) [47]   HCM
  27, IVS 17, D:A→T, 4 (8.3/5.2) [13]   HCM
  28, IVS 17, D:G→A, 1 (8.3/-4.5) [48]   HCM
  29, IVS 17, D:G→C, 1 (8.3/-1.5) [49]   HCM
  30, IVS 21, D:G→A, 1 (4.0/-9.8) [50]   HCM
  31, IVS 21, D:T→G, 2 (4.0/-4.2) [51]   HCM
  32, IVS 21, D:T→G, 2 (4.0/-4.2) [51]   HCM
  33, IVS 23, D:G→A, 1 (7.3/-5.5) [41]   HCM
  34, IVS 23, D:G→T, 1 (7.3/-0.5) [40]   HCM
  35, IVS 27, D:G→A, 1 (4.9/-9.0) [52]   HCM
  36, IVS 29, D:G→A, 1 (5.9/-6.9) [53]   DCM
  37, IVS 29, D:G→A, 5 (5.9/2.4) [42]   HCM
  38, IVS 30, D:T→C, 2 (9.4/1.0) [46]   HCM
  39, IVS 30, D:T→G, 2 (9.4/0.2) [54]   HCM
  40, IVS 30, D:G→C, 5 (9.4/4.5) [55]   HCM
  41, IVS 31, D:G→A, 1 (3.6/-9.2) [56]   HCM
  42, IVS 31, D:G→T, 1 (3.6/-4.2) [57]   DCM
  43, IVS 32, D:G→A, 1 (9.9/-4.0) [40]   HCM
  44, IVS 32, D:T→A, 2 (9.9/1.0) [58]   HCM
MYH7 45, IVS 8, D:G→A, 1 (5.0/-7.8) [59]   HCM
  46, IVS 8, D:G→C, 3 (5.0/0.6) [59]   HCM
PKP2 47, IVS 1, D:G→A, 1 (10.5/-2.3) [31]   ARVD
  48, IVS 4, D:G→A, 1 (10.3/-2.5) [31]   ARVD
  49, IVS 5, D:G→A, 1 (4.8/-9.0) [60]   ARVD
  50, IVS 5, D:G→C, 1 (4.8/-5.0) [31]   ARVD
  51, IVS 7, D:G→A, 1 (9.4/-4.4) [31]   ARVD
  52, IVS 10, D:G→C, 1 (9.4/-1.4) [61]   ARVD
  53, IVS 12, D:G→T, 1 (11.0/3.2) [61]   ARVD
  54, IVS 12, D:C→T, -6 (11.0/11.0) [61]   ARVD
  55, IVS 12, D:G→A, 1 (11.0/-1.8 ) [62]   ARVD
TNNT2 57, IVS 16, D:G→A, 1 [63]   HCM
The coordinate is the numerical location of the base in Genbank sequence. It is illustrated as the relative position in the numbered IVS (Intervening sequence) donor (D) splice site. Positive integers indicate 3’ (downstream) location; negative integers indicate 5’ (upstream) location. Ri(n)--Ri value of natural splice sites; Ri(m)--Ri value of mutant splice sites
Table 2: Information contents of the splice-mutations at donor sites.